Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications

Clinical Pharmacokinetics

Volumn 35, Issue 1, 1998, Pages 49-64

  Hämmerlein, Andrea ^a   Derendorf, Hartmut ^a   Lowenthal, David T ^b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICOAGULANT AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

AGED; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; GERIATRIC CARE; HUMAN; KIDNEY FUNCTION; LIVER METABOLISM; NEUROENDOCRINE SYSTEM; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

AGED; AGED, 80 AND OVER; AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; BENZODIAZEPINES; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR PHYSIOLOGY; CENTRAL NERVOUS SYSTEM; DIGOXIN; DRUG THERAPY; GLOMERULAR FILTRATION RATE; HUMANS; LIVER; PHARMACOKINETICS;

EID: 0031854072     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199835010-00004     Document Type: Review

References (125)

1. Baum C, Kennedy D, Forbes M, et al. Drug use in the United States in 1981. JAMA 1981; 251: 1293-7
2. Shock N. Normal human aging: the Baltimore Longitudinal Study of Aging [Publication No. 84]. Washington, DC: US Government Printing Office, 1984: 2450
3. Tumer N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol 1992; 32: 271-302
4. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations: Pt I. Clin Pharmacokinet 1991; 21 (3): 165-77
5. Delafuente JC. Perspectives on geriatric pharmacotherapy. Pharmacotherapy 1991; 11 (3): 222-4
6. Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital [see comments]. J Am Geriatr Soc 1989; 37 (4): 323-6
7. Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26 (2): 181-6
8. Bender A. Effect of age on intestinal absorption: implications for drug absorption in the elderly. J Am Geriatr Soc 1968; 16: 1331-9
9. Geokas M, Haverback B. The aging gastrointestinal tract. Am J Surg 1969; 117: 881-92
10. Richey D, Bender A. Pharmacokinetics consequences of aging. Annu Rev Pharmacol Toxicol 1977; 17: 49-65
11. Evans M, Triggs E, Cheung M, et al. Gastric emptying rate in the elderly: implications for drug therapy. J Am Geriatr Soc 1981; 29: 201-5
12. Bender A. The effect of increasing age on the distribution of peripheral blood flow in man. J Am Geriatr Soc 1965; 13: 192-8
13. Evans M, Triggs E, Broe G, et al. Systemic availability of orally administered L-dopa in the elderly parkinsonian patient. Eur J Clin Pharmacol 1980; 17: 215-21
14. Castleden C, George C. The effect of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol 1979; 7: 49-54
15. Larsson M, Landahl S, Lundborg P, et al. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol 1984; 27: 217-22
16. Ho P, Triggs E. Drug therapy in the elderly. Aust NZ J Med 1984; 14: 179-90
17. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982
18. Peck C. Bedside clinical pharmacokinetics. Rockville (MD): Pharmacometric Press, 1985
19. Collart P, Poitevin M, Milovanovic A, et al. Kinetic, study of, serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people. Br J Vener Dis 1980; 56: 355-62
20. Douglas J, Bax R, Munro J. The pharmacokinetics of cefuroxime in the elderly. J Antimicrob Chemother 1980; 6: 543-9
21. Phillips S, Bararaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing-home acquired pneumonia. J Am Geriatr Soc 1993; 4: 1071-4
22. Shock N, Watkin D, Yiengst B, et al. Age differences in water content of the body as related to basal oxygen consumption in males. J Gerontol 1963; 18: 1-8
23. Forbes G, Reina J. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970; 19: 653-63
24. Adelman L, Liebman J. Anatomy of body water and electrolytes. Am J Med 1959; 27: 256-77
25. Lowenthal D. Clinical pharmacology. In: Abrams W, Berkow R, editor. Merck manual of geriatrics. Rahway (NJ): Merck & Co Inc. 1990
26. Lakatta E. Age-related alteration in the cardiovascular response to adrenergic-mediated stress. Fed Proc 1980; 39: 3173-7
27. Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the normative aging study. J Gerontol 1988; 43 (1): M18-20
28. Schmucker D. Aging and drug disposition: an update. Pharmacol Rev 1985; 37: 133-48
29. Wallace S, Whiting B. Factors affecting drug binding in plasma of elderly patients. Br J Clin Pharmacol 1976; 3: 327-30
30. Paxton J. Alpha 1 acid glycoprotein and binding of basic drugs. Methods Find Exp Clin Pharmacol 1983; 5: 635
31. Piafsky K. Disease induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 1980; 5: 246-62
32. O'Malley K, Crooks J, Duke E, et al. Effects of age and sex on human drug metabolism. BMJ 1971; 3: 607-9
33. Vestal R, Wood A, Branch R, et al. Effect of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 1979; 26: 8-15
34. Bach B, Hansen J, Kampmann J, et al. Disposition of antipyrine and phenytoin correlated with age and liver volume in men. Clin Pharmacokinet 1981; 6: 389-96
35. Crooks J, Stephenson I. Drugs and the elderly. London: Macmillan, 1979
36. Sotaniemi EA, Arranto AJ, Pelkonen O, et al. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther 1996; 61 (3): 331-9
37. Schmucker DL, Woodhouse KW, Wang RK, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990; 48 (4): 365-74
38. Yuen G. Altered pharmacokinetics in the elderly. Clin Geriatr Med 1990; 6: 257-67
39. Divoll M, Abernethy D, Ameer B, et al. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther 1982; 31: 151-6
40. Abernethy D, Greenblatt D, Shader R. Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther 1985; 232: 183-8
41. Wood A, Vestal R, Wilkinson G, et al. The effect of aging and cigarette smoking on the elimination of antipyrine and indocyanine green elimination. Clin Pharmacol Ther 1979; 26: 16-20
42. Twun-Barima Y, Finnigan T, Habash A, et al. Impaired enzyme induction by rifampicin in the elderly [letter]. Br J Clin Pharmacol 1984; 17: 595-7
43. Davies D, Shock N. Age changes in glomerular filtration rates, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496-507
44. Rowe J, Andres R, Tobin J, et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-63
45. Landahl S, Aurell M, Jagenburg R. Glomerular filtration rate at the age of 70 and 75. J Clin Exp Geront 1982; 3: 29-45
46. Watkin D, Shock N. Agewise standard value for Cin, Cpah and Tmpah in adult males. J Clin Invest 1955; 34: 965
47. Trollfors B, Norrby R. Estimation of glomerular filtration rate by serum creatinine and serum beta-2-microglobulin. Nephron 1981; 28: 196-9
48. Kim K, Onesti G, Ramirez O, et al. Creatinine clearance in renal disease: a reappraisal. BMJ 1969; 4: 11-4
49. Cockroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
50. Baum C, Kennedy D, Forbes M. Utilization of nonsteroidal antiinflamatory drugs. Arthritis Rheum 1985; 28: 686-92
51. Taha A, Lenton R, Murdoch P, et al. Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem. Br Med J Clin Res Ed 1985; 291: 661-2
52. Unworth J, Sturman S, Lunec J, et al. Renal impairment associated with nonsteroidal antiinflamatory drugs. Ann Rheum Dis 1987; 46: 233-6
53. Ciabattoni G, Cinotti G, Pierucci A, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med 1984; 310: 279-83
54. Murray M, Brater D. Nonsteroidal antiinflammatory drugs. Clin Geriatr Med 1990; 6: 365-97
55. Cornoni-Huntley J, Brock D, Ostfeldt A, et al. Established populations for epidemiologic studies of the elderly. Resource data book [publication no. 86]. Washington, DC: US Government Printing Office, 1986: 2443
56. Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatr Med 1990; 6 (2): 269-83
57. Lippa AS PR, Beer B, Critchet DJ, et al. Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging 1980; 1: 13-9
58. Abrass IB, Davis JL, Scarpace PJ. Isoproterenol responsiveness and myocardial beta-adrenergic receptors in young and old rats. J Gerontol 1982; 37 (2): 156-60
59. Roth G, Hess G. Changes in the mechanisms of hormone neurotransmitter action during aging. Current status of the role of receptor and postreceptor alterations: a review. Mech Ageing Dev 1982; 20: 175-94
60. Guarnieri T, Filburn CR, Zitnik G, et al. Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart. Am J Physiol 1980; 239 (4): H501-8
61. Shimazu I, Takeda A, Fukushima Y. Neural-metabolic interaction in the liver during aging in rats. In: Kilani K, editor. Liver and aging. Amsterdam: Elsevier, 1986: 171-81
62. Borst S, Scarpace P. Reduced high-affinity alpha 1-adrenoceptors in liver of senescent rats: implications of assessment at various temperatures. Br J Pharmacol 1990; 101: 650-4
63. Morley J, Flood J, Silver A. Opioid peptides and aging. Ann NY Acad Sci 1990; 579: 123-32
64. Roth G. Mechanisms of altered hormone-neurotransmitter action during aging: from receptors to calcium mobilization. Ann Rev Gerontol Geriatr 1990; 10: 132-46
65. Peterson C. Changes in calcium's role as messenger during aging in neuronal and nonneuronal cells. Ann NY Acad Sci 1992; 663: 279-93
66. Castleden CM, George CF, Marcer D, et al. Increased sensitivity to nitrazepam in old age. BMJ 1977; 1: 10-12
67. Larsson E, Kukull W, Buchner D, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987; 107: 169-73
68. Bender A. Pharmacologic aspects of aging: a survey of the effect of age on drug activity in adults. J Am Geriatr Soc 1964; 12: 114-34
69. Kallman H. Depression in the elderly. Compendium of three years of clinical use. Proceedings of Symposium on Desyrel®. 1984 Sep 14; Evansville (IL): Mead-Johnson Pharmaceut Division, 1985: 31-40
70. Gribbin B, Pickering T, Sleight P, et al. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971; 29: 424-31
71. McGarry K, Laher M, Fitzgerald D, et al. Baroreflex function in elderly hypertensives. Hypertension 1975; 5: 763-6
72. Schatz I. Orthostatic hypotension: I. Functional and neurogenic causes. Arch Intern Med 1984; 144: 773-7
73. Schatz I. Orthostatic hypotension: II. Clinical diagnosis, testing and treatment. Arch Intern Med 1984; 144: 1037-41
74. Come P, Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 1976; 54: 624-8
75. Alpert J. Nitrate therapy in the elderly. Am J Cardiol 1990; 65: 23J-7J
76. Weidmann P, De Myttenaere-Bursztein S, Maxwell M, et al. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 1975; 8: 325-33
77. Epstein M, Hollenberg N. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 1976; 87: 411-7
78. Buhler F, Hulthen U, Kiowski W, et al. The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol 1982; 4 Suppl. 3: 5350-7
79. Shannon R, Minaker K, Rowe J. Aging and water balance in humans. Semin Nephrol 1984; 4: 346-53
80. Rowe J, Shock N, deFronzo R. The influence of age on the renal response to water deprivation in man. Nephron 1976; 17: 270-8
81. Lindeman R, Lee Jr T, Yiengst M, et al. Influence of age, renal disease, hypertension, diuretics and calcium on the antidiuretic response to suboptimal infusions of vasopressin. J Lab Clin Med 1966; 68: 206-23
82. Rowe S, Minaker K, Sparrow D, et al. Age-related failure of volume-pressure-mediated vasopressin release. J Clin Endocrinol 1982; 54: 661-4
83. Geller J. Benign prostatic hyperplasia: pathogenesis and medical therapy. J Am Geriatr Soc 1993; 39: 1208-16
84. Crooks J. Aging and drug disposition: pharmacodynamics. J Chronic Dis 1983; 36 (1): 85-90
85. Davies KN, Castleden CM. Ageing and receptors. In: Grimley-Eivans J, Caird FI, editors. Advanced geriatric medicine. London: Wright, 1988
86. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature 1976; 261 (5558): 333-5
87. Pan H, Hoffmann B, Pershe R, et al. Decline in beta-adrenergic receptor-mediated relaxation with aging in man. J Pharmacol Exp Ther 1986; 239: 802-7
88. Ford G, Hoffmann B, Vestal R, et al. Age-related changes in adenosine and beta-adrenergic responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol 1992; 33: 83-8
89. 1 and beta-adrenergic responsiveness of vascular smooth muscle in adult males. J Gerontol 1989; 44: M13-7
90. Brummelen P, Buhler F, Kiowski W, et al. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci 1981; 60: 571-7
91. Ford GA, James OFW. Effect of autonomic blockade on cardiac beta-adrenergic chronotropic pesponsiveness in healthy young, healthy elderly and endurance-trained elderly subjects. Clin Sci 1994; 87: 297-302
92. Abrass IB, Scarpace PJ. Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes. J Clin Endocrinol Metab 1982; 55 (5): 1026-8
93. Scarpace PJ. Decreased receptor activation with age: can it be explained by desensitization? J Am Geriatr Soc 1988; 36 (11): 1067-71
94. Conolly MJ. Aging, late-onset asthma and the beta-adrenoceptor. Pharmacol Ther 1993; 60 (3): 389-404
95. Brawn LA, Castleden CM. Adverse drug reactions: an overview of special considerations in the management of the elderly patient. Drug Saf 1990; 5 (6): 421-35
96. Conolly M, Crowley J, Nielson C, et al. Peripheral mononuclear leucocyte beta-adrenoceptor and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients. Thorax 1994; 49: 26-32
97. Feldmann R, Limbild L, Nadeau J, et al. Alterations in leukocyte beta-receptor affinity with aging: a potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med 1984; 310: 815-9
98. Sowinski K, Forrest A, Wilton J, et al. Effect of aging on atelonol pharmacokinetics and pharmacodynamics. J Clin Pharmacol 1995; 35 (8): 807-14
99. Elliot H. Calcium antagonists in the treatment of hypertension and angina pectoris in the elderly. J Cardiovasc Pharmacol 1989; 13 Suppl. 4: S12-S16
100. Schwartz J, Troconiz I, Verotta D, et al. Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil. J Pharmacol Exp Ther 1993; 265 (2): 690-8
101. Robertson D, Waller A, Renwick C, et al. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 1988; 25 (3): 297-305
102. Donnelly R, Elliott H. Factors influencing the response to calcium antagonists in elderly patients with hypertension and ischaemic heart disease. Exp Gerontol 1990; 25 (3-4): 375-81
103. Lettieri J, Krol G, Yeh S, et al. The effects of age and race on nitrendipine pharmacokinetics and pharmacodynamics. J Cardiovasc Pharmacol 1988; 12 Suppl. 4: S129-32
104. Macdonald N, Sioufi A, Howie C, et al. The effect of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol 1993; 36 (3): 205-9
105. Andros E, Detmar-Hanna D, Suteparuk S, et al. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol 1996; 50 (1-2): 41-6
106. Kelly J, O'Malley K. Nitrates in the elderly: pharmacological considerations. Drugs Aging 1992; 2 (1): 14-9
107. Tsang P, Gerson B. Understanding digoxin use in the elderly patient. Clin Lab Med 1990; 10 (3): 479-92
108. Mooradian A. Digitalis: an uptake of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations. Clin Pharmacokinet 1988; 15: 165-79
109. Kennedy R, Seilen E. Ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat letf atrial muscle. J Pharmacol Exp Ther 1989; 248: 104-10
110. Ruiz J, Array S, Lowenthal D. Therapeutic drug monitoring in the elderly. Am J Ther 1996; 3: 839-60
111. Shepherd AM, Hewick DS, Moreland TA, et al. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 1977; 4 (3): 315-20
112. Husted S, Andreasen F. The influence of age on the response to anticoagulants. Br J Clin Pharmacol 1977; 4 (5): 559-65
113. O'Malley K, Kelly J, Swift C. Responsiveness to drugs. In: Swift C, editor. Clinical pharmacology in the elderly. New York: Marcel Dekker, 1987: 83-101
114. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303-7
115. Greenblatt DJ, Allen MD. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol 1978; 5 (5): 407-13
116. 14C]nitrazepam in young and old rats. J Pharm Pharmacol 1978; 30 (5): 318-9
117. Greenblatt DJ, Allen MD, Harmatz, JS, et al. Diazepam disposition determinants. Clin Pharmacol Ther 1980; 27 (3): 301-12
118. Reidenberg M, Levy M, Warner H. Relationship between diazepam ldose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther 1978; 23: 371-4
119. Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation, and alcohol. Br Med J Clin Res Ed 1984; 289 (6441): 351-3
120. Greenblatt D, Ehrenberg B, Scavone J, et al. Increased sensitivity to midazolam in the elderly. Clin Pharmacol Therr 1990; 47: 210
121. Kanto J, Kangas L, Aaltonen L, et al. Effect of age on the pharmacokinetics and sedative effect of flunitrazepam. J Clin Pharmacol 1981; 19: 400-4
122. Memo M, Spano PF, Trabucchi M. Brain benzodiazepine receptor changes during ageing [letter]. J Pharm Pharmacol 1981; 33 (1): 64
123. Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation: current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharniacokinet 1995; 29 (3): 192-209
124. Ozdemir V, Fourie J, Busto U, et al. Pharmacokinetic changes in the elderly: do they contribute to drug abuse and dependence? Clin Pharmacokinet 1996; 31 (5): 372-85
125. Rochon PA, Gurwitz JH. Drug therapy. Lancet 1995; 346 (8966): 32-6